#Healthcare Policy

Trump Administration Takes Action on Medicare Drug Price Negotiation Loophole

The Trump administration has announced measures aimed at addressing a loophole in Medicare drug price negotiations, which could affect costs for beneficiaries and pharmaceutical companies.